| 02 Sept, 11:38 am | procedural | 0 | Corrigendum to the Notice of Postal Ballot dated August 3, 2026, updating procedural details for the postal ballot. | nse |
| 26 Aug, 02:39 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Volume Movement Letter | bse |
| 26 Aug, 02:03 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd | bse |
| 19 Aug, 05:28 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 19 Aug, 05:26 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 06 Aug, 07:59 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 06 Aug, 07:57 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passed | nse |
| 06 Aug, 07:51 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Aug, 07:47 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 05 Aug, 03:07 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 05 Aug, 03:04 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 03 Aug, 08:46 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 03 Aug, 08:44 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 03 Aug, 08:41 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 03 Aug, 04:19 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 03 Aug, 04:18 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 03 Aug, 04:16 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Cessation of Subesh Wiliams as Non- Executive Director of the company w.e.f. August 03, 2026. | nse |
| 03 Aug, 04:14 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Aug, 04:12 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Resignation of Director | bse |
| 03 Aug, 04:11 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 03 Aug, 04:10 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 03 Aug, 04:09 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 03 Aug, 04:07 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 03, 2026, titled "Press Release". | nse |
| 03 Aug, 04:05 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 03 Aug, 04:00 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 03 Aug, 04:00 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 03 Aug, 03:48 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Results For Quarter 30Th June 2026 | bse |
| 03 Aug, 03:43 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Outcome for Outcome Of Meeting | bse |
| 21 Jul, 11:59 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Approve And Take On Record The Un-Audited Financial Results For The First Quarter Ended 30Th June 2026. | bse |
| 25 Jun, 11:46 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passed | nse |
| 25 Jun, 11:38 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 08 Jun, 11:50 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Letter for weblink for Annual Report '. | nse |
| 08 Jun, 11:42 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Letter For Website Link For Annual Report | bse |
| 05 Jun, 08:30 pm | — | … | BRSR Report | nse |
| 05 Jun, 07:45 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Reg. 34 (1) Annual Report. | bse |
| 29 May, 12:53 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 29 May, 12:45 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Cessation of Dr Simrat Sohal as Other of the company w.e.f. August 05, 2026. | nse |
| 29 May, 12:38 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 26 May, 10:24 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 18 May, 01:05 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 18 May, 01:03 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 May, 07:35 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 13 May, 07:34 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 May, 03:52 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated 0 , , titled "Press release ". | nse |
| 13 May, 03:50 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 May, 03:45 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 13 May, 03:16 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Corporate Action-Board approves Dividend | bse |
| 13 May, 03:05 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Dividend Updates | bse |
| 13 May, 03:00 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 13 May, 02:56 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-May-2026. | nse |